Sugati Ventures
Venture capitalActively deployingSeed–Series A · 8 people tracked
Investment thesis
Sugati Ventures invests in early-stage healthcare technology entrepreneurs, providing capital, industry expertise, and access to a global ecosystem of corporate partners, investors, and customers to drive portfolio company success.
Source: firm website, verified Jul 21, 2026.
Team · 8 people
from the firm's websiteFounder and Managing Director of Science Futures, established in 1983 to provide investment advisory services in biotechnology. Co-founder of Sequenom (NASDAQ 2000, acquired by Lab Corp in 2021) and Agena Biosciences. Previously partner at TVM Capital and has served on numerous public and private company boards. Currently leads femtech investments at Portfolia.
Biomedical engineer and clinical operations consultant with 15+ years of experience in FDA medical device and consumer product trials. Led clinical efforts for multiple FDA 510(k) clearances and was instrumental in Nutrafol's acquisition by Unilever. Currently Senior Director of Clinical Trials at Unilever. Holds degrees in Chemical Engineering and Biomedical Engineering.
Healthcare systems engineer with expertise in process improvement, systems thinking, and data analytics. She holds a Master's of Science from Lehigh University and previously interned at Sugati Ventures as a Business Strategist, where she explored AI integration for healthcare system optimization. She now manages communications and thought leadership.
Seasoned business strategist and venture leader with deep fund management and business operations experience. Previously Senior Associate at Growth Factory Ventures overseeing operations and portfolio performance across 60+ health and life sciences startups. Currently oversees Urgent Care operations at Sutter Health. Holds a Master of Science in Health Law.
Outcomes-focused leader with experience spanning venture capital, healthcare marketing, supply chain management, and R&D across major corporations and startups including Philips, Johnson & Johnson, and Handshake Solutions. She has managed global manufacturing networks and led commercial launches for breakthrough healthcare products. She brings healthcare and technology expertise to support portfolio companies' strategy and execution.
CEO and Chief Scientist of Perceive Now, Inc., developing AI-driven platforms that transform patent, market, regulatory, and clinical data into decision-ready intelligence for healthcare and biotech innovators. With 7+ years at the intersection of AI, diagnostics, and IP strategy, she has built systems used by 50+ biotech clients. Holds a Ph.D. in microfluidics and lab-on-chip diagnostics.
Healthcare practitioner and business leader with experience at TEMASEK, Singapore's Economic Development Board, and Big4 advisory firms KPMG and Deloitte. Advises global investors, governments, and life sciences companies on business model innovation, market entry, M&A strategy, and technology deployment. Currently serves on various boards and teaches at National University of Singapore.
What they invest in
from 4 of 11 portfolio companiesMedical Devices ×4AI & Machine Learning ×3Digital Health ×2Healthtech ×2Biotech ×1
HQs:United States×1
Investments · 11 tracked
founders shown can be your intro pathNeurava develops AI-powered wearable devices designed to monitor seizures and cardiorespiratory dysfunction in people with epilepsy, aiming to mitigate the risk of SUDEP (Sudden Unexpected Nocturnal Death in Epilepsy). The company combines neuromodulation expertise with machine learning to create a novel medical device platform for epilepsy management.
AI & Machine LearningHealthtechMedical DevicesBaltimore, US
Vivek Ganesh, PhD(Co-founder)Jay Shah, PhD(Co-founder)Trevor Meyer, PhD(Co-founder)
An AI-powered lung cancer screening and diagnosis platform that partners with community health centers to identify high-risk patients and support radiologist diagnosis.
Oatmeal Health develops LungAI CADx, an AI-powered tool that provides malignancy risk scores for lung nodules embedded within radiology workflows to improve early lung cancer detection. The product serves health systems, radiologists, and pulmonologists to increase diagnostic accuracy and enable earlier-stage cancer diagnoses.
AI & Machine LearningDigital HealthMedical Devices
<UNKNOWN>
An enterprise operating system that delivers explainable AI with verified decision-making and safe automation across Microsoft, macOS, and Linux platforms.
Develops a non-invasive solution using alternating magnetic field technology to treat infected metallic implants by eradicating biofilms.
Uses MAP technology to build functional tissue and organs for disease treatment through immunomodulation and material science.
Tempo Thera develops tissue engineering products using MAP technology that combine immunomodulation and material science for soft tissue reconstruction in surgical settings. The company builds functional tissue and organs to treat patients with dermal and abdominal wall indications, with expanding pipeline into drug delivery, cell engraftment, and vaccine technologies.
BiotechHealthtechMedical Devices
Offers Laso, a remote patient monitoring platform leveraging AI to detect surgical site infections early and alert healthcare providers.
Truss Health offers Laso, a remote patient monitoring platform that uses AI and sensors to detect surgical site infections early after procedures like orthopedic, cardiac, abdominal, and obstetric surgeries. The platform helps healthcare providers intervene promptly to prevent complications and reduce hospital readmissions.
AI & Machine LearningDigital HealthMedical Devices
Frequently asked questions
- What stage does Sugati Ventures invest at?
- Sugati Ventures invests at the Seed, Series A stages.
- What sectors does Sugati Ventures focus on?
- Sugati Ventures focuses on Healthtech.
Images
Similar investors
8VC is a technology investment firm focused on building and investing in ambitious companies across life sciences, healthcare, manufacturing, enterprise, logistics, and defense sectors, with particular emphasis on operational intelligence and data-driven decision-making.
a16z is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz that invests in seed through growth-stage technology companies across multiple sectors including AI, healthcare, consumer, crypto, enterprise, fintech, and gaming. The firm manages over $100 billion in assets and operates a distinctive platform model with a large team of operators supporting founders throughout their journey.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Bessemer Venture Partners is a venture capital firm with a 50-year history supporting entrepreneurs in building enduring companies globally. The firm draws on deep operational expertise and advisory relationships to support portfolio companies through their growth journey.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.